Dose recommendations for anticancer drugs in patients with renal or hepatic impairment.
Lancet Oncol. 2019 Apr;20(4):e200-e207. doi: 10.1016/S1470-2045(19)30145-7.
Lancet Oncol. 2019.
PMID: 30942181
Review.